Adage Capital Partners’s Immunogen Inc IMGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-971,928
| Closed | -$28.8M | – | 974 |
|
|
2023
Q4 | $28.8M | Buy |
971,928
+771,928
| +386% | +$15.4M | 0.06% | 331 |
|
|
2023
Q3 | $3.17M | Sell |
200,000
-450,000
| -69% | -$7.48M | 0.01% | 711 |
|
|
2023
Q2 | $12.3M | Sell |
650,000
-16,982,815
| -96% | -$201M | 0.03% | 529 |
|
|
2023
Q1 | $67.7M | Buy |
17,632,815
+6,513,815
| +59% | +$27.8M | 0.15% | 163 |
|
|
2022
Q4 | $55.2M | Buy |
11,119,000
+3,219,000
| +41% | +$17.5M | 0.13% | 189 |
|
|
2022
Q3 | $37.8M | Sell |
7,900,000
-3,686,193
| -32% | -$19.4M | 0.09% | 232 |
|
|
2022
Q2 | $52.1M | Hold |
11,586,193
| – | – | 0.12% | 178 |
|
|
2022
Q1 | $55.1M | Buy |
11,586,193
+1,300,000
| +13% | +$7.2M | 0.1% | 190 |
|
|
2021
Q4 | $76.3M | Buy |
10,286,193
+2,536,193
| +33% | +$15.8M | 0.14% | 157 |
|
|
2021
Q3 | $43.9M | Buy |
7,750,000
+750,000
| +11% | +$4.33M | 0.09% | 237 |
|
|
2021
Q2 | $46.1M | Buy |
7,000,000
+2,500,000
| +56% | +$17.4M | 0.09% | 226 |
|
|
2021
Q1 | $36.5M | Buy |
4,500,000
+2,025,000
| +82% | +$16.5M | 0.07% | 287 |
|
|
2020
Q4 | $16M | Buy |
+2,475,000
| New | +$14.4M | 0.03% | 477 |
|